Literature DB >> 2271858

Has adjuvant treatment of breast cancer had an unfair trial?

I Mittra1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2271858      PMCID： PMC1664434          DOI： 10.1136/bmj.301.6764.1317

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Dose-intense adjuvant treatment of high-risk breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

2.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

3.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

4.  Why data bases should not replace randomized clinical trials.

Authors:  D P Byar
Journal:  Biometrics       Date:  1980-06       Impact factor: 2.571

5.  Predicting breast cancer recurrence.

Authors:  B Stenkvist; E Bengtsson; B Dahlqvist; G Eklund; O Eriksson; T Jarkrans; B Nordin
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

6.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

7.  Steroid-hormone receptors in breast cancer.

Authors:  J L Wittliff
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

8.  Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.

Authors:  C Rose; S M Thorpe; K W Andersen; B V Pedersen; H T Mouridsen; M Blichert-Toft; B B Rasmussen
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

9.  Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer.

Authors:  J R Sainsbury; J R Farndon; G V Sherbet; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

10.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640
View more
  2 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases.

Authors:  C Wright; J Cairns; B J Cantwell; A R Cattan; A G Hall; A L Harris; C H Horne
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.